Clinical Trials Directory

Trials / Completed

CompletedNCT04627155

A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Human Tolerance and Kinetics of LY03003 By Single Intramuscular Injection

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Luye Pharma Group Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is to evaluate the human tolerance and pharmacokinetics of LY03003.

Conditions

Interventions

TypeNameDescription
DRUGLY03003Rotigotine,extended-release microspheres

Timeline

Start date
2013-03-15
Primary completion
2013-05-20
Completion
2013-05-20
First posted
2020-11-13
Last updated
2020-11-13

Source: ClinicalTrials.gov record NCT04627155. Inclusion in this directory is not an endorsement.

A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 (NCT04627155) · Clinical Trials Directory